GRIM
ANAB icon

Greenhaven Road Investment Management’s AnaptysBio ANAB Stock Holding History

Greenhaven Road Investment Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Buy
+171,059
New +$10.4M 7.5% 7

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Greenhaven Road Investment Management's ANAB Position: Q2 2026 in Review

Greenhaven Road Investment Management opened a new position in AnaptysBio (ANAB) in Q2 2026: 171,059 shares worth $11.5M. The stake represents 7.5% of the portfolio and ranks #7 among its holdings.

213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Greenhaven Road Investment Management held 171,059 shares of AnaptysBio worth $11.5M as of Q2 2026.
  • AnaptysBio was a new Greenhaven Road Investment Management position in Q2 2026.
  • AnaptysBio made up 7.5% of Greenhaven Road Investment Management's portfolio in Q2 2026, its #7 holding.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Greenhaven Road Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.